Skip to content

Ketones Influence on Glucose Metabolism in Brain. A Human Positron Emission Tomography (PET) Study

Ketones Influence on Glucose Metabolism in Brain. A Human Positron Emission Tomography (PET) Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02357550
Enrollment
9
Registered
2015-02-06
Start date
2015-03-31
Completion date
2016-01-31
Last updated
2016-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ketone Body Metabolism, Brain Metabolism

Brief summary

This project tend to investigate the affection of ketone bodies on brain metabolism. This will be done by measuring human cerebral uptake of energy substrates, together with functional parameters, using PET imaging and appropriate radiotracers under hyperketonemia in healthy subjects by ketone infusion. Hypotheses 1. Increased levels of ketone bodies in healthy subjects leads to decreased glucose uptake by brain cells contributing to hyperglycaemia. 2. Increased levels of ketone bodies in healthy subjects leads to increased cerebral blood flow. 3. Altered oxygen consumption during hyperketonemia in healthy subjects.

Interventions

DRUGketone

3-OHB is infused intravenously.

DRUGplacebo

Saline infusion.

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * BMI 20-30 kg/m2

Exclusion criteria

* smoking * alcohol abuse * severe comorbidity * blood donation 6 month prior * claustrophobia

Design outcomes

Primary

MeasureTime frameDescription
Glucose metabolism in brain, CMRt=240-360 minutescerebral glucose metabolism measured by PET tracer during the above time frame

Secondary

MeasureTime frameDescription
Stress metabolism0-360 minutesgrowth hormone, cortisol, glucagon, adrenalin, ghrelin.
Oxygen useT=150-200 minutescerebral oxygen consumption measured by PET tracer during the above time frame
cerebral blood flowt=180-250 minutescerebral blood flow measured by PET tracer during the above time frame
Intramuscular signalingt= 260 minutesprotein and insulin signaling in muscle

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026